Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00603057

NCT00603057
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with a type of lung cancer called Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC), confirmed by a tissue sample or by a special scan called a FDG-PET that shows signs of cancer.
  • Your lung cancer is at a stage between Stage I and Stage III, and your treatment plan includes radiation therapy, with or without chemotherapy.
  • You may still be eligible if your lung cancer has come back in the same area after surgery, as long as you meet the other requirements.
  • You are 18 years of age or older.
  • If you are a woman who could become pregnant, you must be willing to use effective birth control during the trial.
  • You are willing and able to sign a consent form agreeing to take part in the study.

Who may not be able to join:

  • You have a build-up of fluid caused by cancer around your lungs or heart.
  • You are currently pregnant.
  • You are currently breastfeeding.
  • You have diabetes and your blood sugar levels are not well controlled (fasting blood sugar above 200 mg/dl).
  • You are unable to lie still and flat for approximately 45 minutes at a time, which is needed for the scans used in this study.
  • You are currently incarcerated (in prison).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University of Michigan Rogel Cancer Center
Registry
clinicaltrials_gov
Start date
1 May 2007
Est. completion
1 September 2013

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The primary aim of this study is to investigate predictive models for long-term tumor control and late treatment lung toxicity by using FDG-PET-CT, V/Q SPECT-CT and blood tests during the course of radiation therapy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov